Epic patent gaming, and pay-for-delay agreements to slow-walk introduction of cheaper generics to market, helped bring us to this point. But will a growing behemoth of 750 hospitals actually lower drug prices?
An article in the Oct. 12th New York Times takes an astounding 3800 words to make one point: Drug companies are charging much more (too much?) for their products in the U.S. compared to other parts of the world.
